157 related articles for article (PubMed ID: 34382326)
1. Dehydrozingerone inhibits renal lipotoxicity in high-fat diet-induced obese mice.
Lee ES; Kang JS; Kim HM; Kim SJ; Kim N; Lee JO; Kim HS; Lee EY; Chung CH
J Cell Mol Med; 2021 Sep; 25(18):8725-8733. PubMed ID: 34382326
[TBL] [Abstract][Full Text] [Related]
2. Dehydrozingerone exerts beneficial metabolic effects in high-fat diet-induced obese mice via AMPK activation in skeletal muscle.
Kim SJ; Kim HM; Lee ES; Kim N; Lee JO; Lee HJ; Park NY; Jo JY; Ham BY; Han SH; Park SH; Chung CH; Kim HS
J Cell Mol Med; 2015 Mar; 19(3):620-9. PubMed ID: 25582026
[TBL] [Abstract][Full Text] [Related]
3. Effect of dehydrozingerone, a half analog of curcumin on dexamethasone-delayed wound healing in albino rats.
Rao MC; Sudheendra AT; Nayak PG; Paul P; Kutty GN; Shenoy RR
Mol Cell Biochem; 2011 Sep; 355(1-2):249-56. PubMed ID: 21567208
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
5. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
6. The Nutraceutical Dehydrozingerone and Its Dimer Counteract Inflammation- and Oxidative Stress-Induced Dysfunction of
Profumo E; Buttari B; D'Arcangelo D; Tinaburri L; Dettori MA; Fabbri D; Delogu G; Riganò R
Oxid Med Cell Longev; 2016; 2016():1246485. PubMed ID: 28050226
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
Kim BH; Lee ES; Choi R; Nawaboot J; Lee MY; Lee EY; Kim HS; Chung CH
Yonsei Med J; 2016 May; 57(3):664-73. PubMed ID: 26996567
[TBL] [Abstract][Full Text] [Related]
8. Dibenzoylmethane ameliorates lipid-induced inflammation and oxidative injury in diabetic nephropathy.
Lee ES; Kwon MH; Kim HM; Kim N; Kim YM; Kim HS; Lee EY; Chung CH
J Endocrinol; 2019 Feb; 240(2):169-179. PubMed ID: 30475214
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Wang F; Li R; Zhao L; Ma S; Qin G
Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
[TBL] [Abstract][Full Text] [Related]
11. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
Huang F; Sheng XX; Zhang HJ
Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
Suk Kang J; Son SS; Lee JH; Lee SW; Jeong AR; Lee ES; Cha SK; Chung CH; Lee EY
PLoS One; 2021; 16(4):e0250666. PubMed ID: 33891667
[TBL] [Abstract][Full Text] [Related]
13. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
Lee HS; Suh JY; Kang BC; Lee E
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
[TBL] [Abstract][Full Text] [Related]
14. Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN.
Cui FQ; Wang YF; Gao YB; Meng Y; Cai Z; Shen C; Liu ZQ; Jiang XC; Zhao WJ
J Diabetes Res; 2019; 2019():9512406. PubMed ID: 31886291
[TBL] [Abstract][Full Text] [Related]
15. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N
Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
17. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor
Trasino SE; Tang XH; Shevchuk MM; Choi ME; Gudas LJ
J Pharmacol Exp Ther; 2018 Oct; 367(1):82-94. PubMed ID: 30054312
[TBL] [Abstract][Full Text] [Related]
19. Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia.
Kang MK; Kim SI; Oh SY; Na W; Kang YH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202982
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies.
Moorkoth S; Prathyusha NS; Manandhar S; Xue Y; Sankhe R; Pai KSR; Kumar N
Pharmacol Rep; 2021 Oct; 73(5):1273-1286. PubMed ID: 34181212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
